# Global Research Trends in Dietary Polyphenols for Preventing Non‐Communicable Chronic Diseases: A Bibliometric Study

**Authors:** Xinjiang Huang, Pengyuan Kang, Haiying Chen, Jie Li, Jie Liu

PMC · DOI: 10.1002/fsn3.71539 · Food Science & Nutrition · 2026-03-02

## TL;DR

This study maps global research trends on dietary polyphenols and their role in preventing chronic diseases, showing growth and key research areas.

## Contribution

The paper provides a comprehensive bibliometric analysis of global research trends in dietary polyphenols for NCD prevention.

## Key findings

- Annual publications on dietary polyphenols and NCDs increased from 13 in 1998 to over 160 per year since 2016.
- Research focuses on mechanistic studies of oxidative stress, inflammation, and disease prevention in cancer and cardiometabolic conditions.
- Recent hotspots include gut microbiota, metabolic syndrome, and polyphenol-rich diets, but human trials remain limited.

## Abstract

Dietary polyphenols, a diverse group of plant‐derived bioactives, are widely investigated for their potential to prevent non‐communicable chronic diseases (NCDs), but the structure and evolution of this research field remain unclear. This bibliometric study analyzed 3280 publications on dietary polyphenols and NCDs retrieved from Web of Science Core Collection, PubMed/MEDLINE, and DOAJ (1998–2024) to characterize temporal growth, global contributions, thematic hotspots, and the underlying journal knowledge base. Annual output rose from 13 papers in 1998 to more than 160 per year since 2016, indicating a transition from early expansion to a mature yet active stage. Research is led by teams in the United States, China, Japan, and Western Europe, with increasing participation from Brazil, India, Iran, and other emerging economies, but limited representation from sub‐Saharan Africa. Network and keyword analyses show that the literature is dominated by mechanistic in vitro and animal studies on oxidative stress, inflammation, and signaling pathways, alongside disease‐focused themes in cancer and cardiometabolic prevention. Recent hotspots include metabolic syndrome, obesity, high‐fat diet models, gut microbiota, and polyphenol‐rich dietary patterns, whereas large, long‐term human intervention trials remain relatively scarce. This study underscores the need for integrative, human‐focused, and globally inclusive research programs that test realistic polyphenol‐rich diets on clinically relevant NCD outcomes, and provides a quantitative map to guide priority‐setting for future nutrition and chronic disease research.

This graphical abstract summarizes a bibliometric study on dietary polyphenols for preventing non‐communicable chronic diseases. It shows publication growth from 1998 to 2024, highlights core themes (oxidative stress, inflammation) and hotspots (metabolic syndrome, gut microbiota), and outlines future priorities like long‐term human studies.

## Linked entities

- **Diseases:** cancer (MONDO:0004992), metabolic syndrome (MONDO:0000816), obesity (MONDO:0011122)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, SI (sucrase-isomaltase) [NCBI Gene 6476], INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** metabolic (MESH:D008659), obesity (MESH:D009765), stroke (MESH:D020521), NCDs (MESH:D000073296), Carcinogenesis (MESH:D063646), diabetes (MESH:D003920), poisoning (MESH:D011041), endothelial dysfunction (MESH:D014652), Cancer (MESH:D009369), Alzheimer (MESH:D000544), chronic kidney disease (MESH:D051436), cardiometabolic and oncologic diseases (MESH:D024821), diseases (MESH:D004194), neurodegeneration (MESH:D019636), inflammation (MESH:D007249), coronary heart disease (MESH:D003327), dyslipidemia (MESH:D050171), chronic respiratory disease (MESH:D012140), oncologic (MESH:D000072716), Chronic Diseases (MESH:D002908), cognitive decline (MESH:D003072), adipose tissue (MESH:D018205), breast and other hormone-dependent cancers (MESH:D001943), type 2 diabetes (MESH:D003924), Parkinson (MESH:D010302), cardiovascular disease (MESH:D002318), insulin resistance (MESH:D007333), toxicity (MESH:D064420), atherogenesis (MESH:D050197), hypertension (MESH:D006973), malnutrition (MESH:D044342)
- **Chemicals:** resveratrol (MESH:D000077185), flavonol (MESH:C041477), catechins (MESH:D002392), phenolic acids (MESH:C017616), quercetin (MESH:D011794), flavonols (MESH:D044948), stilbene (MESH:D013267), flavan-3-ol (MESH:C404987), (-)-epigallocatechin gallate (MESH:C045651), anthocyanin (MESH:D000872), glucose (MESH:D005947), flavonoid (MESH:D005419), Polyphenol (MESH:D059808), lipid (MESH:D008055), proanthocyanidins (MESH:D044945), lignan (MESH:D017705), tannin (MESH:D013634), epigallocatechin gallate"[Title (-), proanthocyanidin (MESH:C013221)
- **Species:** Theobroma cacao (cacao, species) [taxon 3641], Camellia sinensis (black tea, species) [taxon 4442], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951362/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951362/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951362/full.md

---
Source: https://tomesphere.com/paper/PMC12951362